new york times semaglutide The Presents: 'Weight of the World' on Ozempic's Rise Older Americans quit weight loss

For patients with Crohns disease and overweight or obesity, GLP-1 receptor agonists appear to be safe and may be associated with meaningful clinical benefits, Ganju told Healio

Morganti P, Bruno C, Colelli G

Related Reading Lilly Weight Loss Drug Diabetes Weight Loss Drug Wegovy Vs Zepbound Weight Loss Zepbound For Weight Loss Pricing and availability current as of June 2026

Data Moats: Capturing real-world evidence on patient responses creates a valuable asset for insurers and pharma

Yes, always inform your GP or diabetes specialist if you are taking berberine, especially if you have diabetes or take regular medications

No, they only brighten the skin and reduce pigmentation scars but cannot change the original skin color